Joyita Dutta, Ph.D.

Advanced non-small cell lung cancer (NSCLC) has only a 4% 5-year survival rate. Determining an optimal treatment plan for patients with late stage non-small cell lung cancer would help to improve the currently low probability of patient survival. Using new and emerging PET/MRI technology, the researchers hope to be able to first reconstruct a high quality 3D PET image of tumors from the motion information of the MRI and then correlate it with the actual outcome in patients. It is hoped that the motion-compensated PET/MRI image could assist in guiding treatment plans for non-small cell lung cancer.